The Burden of Multiple Myeloma on Patients and Caregivers Quality of Life: a Canadian Real-World Study
NCT06610045 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 400
Last updated 2025-03-13
Summary
The purpose of this observational study is to estimate the burden of multiple myeloma on patients and caregivers in terms of QoL. Additionally, this study will assess the correlation between QoL, obtained from commonly used and validated questionnaires, and the perceptions of both patients and caregivers respectively., obtain from a 10-point scale and a comment box.
Conditions
- Multiple Myeloma
- Caregiver Subjective Burden
- Quality of Life (QOL)
Interventions
- OTHER
-
No intervention
No specific intervention is assess in this study.
Sponsors & Collaborators
-
PeriPharm
lead OTHER
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2024-10-15
- Primary Completion
- 2025-02-24
- Completion
- 2025-03-12
Countries
- Canada
Study Locations
More Related Trials
-
Quality of Life of Non-transplant Candidate Multiple Myeloma Patients Treated With Early Bortezomib
NCT01060202 ·Status: COMPLETED
-
Clinical Outcomes and Prognostic Factors in Multiple Myeloma Patients
NCT06457464 ·Status: NOT_YET_RECRUITING
-
Quality of Life in Patients With Asymptomatic Monoclonal Gammopathies
NCT05136807 ·Status: RECRUITING
-
Clinical Decision-making, Prognosis, Quality of Life and Satisfaction in Relapsed/Refractory Multiple Myeloma
NCT03190525 ·Status: ACTIVE_NOT_RECRUITING
-
A Study Assessing the Health-Related Quality of Life (HRQoL) in Participants With Relapsed and/or Refractory Multiple Myeloma (RRMM) With Triple Class Exposure
NCT05217082 ·Status: COMPLETED
-
Cost-Utility Analysis of Home-based Versus Hospital-based Chemotherapy in Multiple Myeloma: Case of Carfilzomib
NCT05184595 ·Status: UNKNOWN ·Phase: NA
-
Non-chemotherapeutic Interventions for the Improvement of Quality of Life and Immune Function in Patients With Multiple Myeloma
NCT05312255 ·Status: RECRUITING ·Phase: NA
-
Myeloma Treatment in Real Life
NCT03638232 ·Status: COMPLETED
-
Quality of Life in Multiple Myeloma Patients Treated With Bortezomib
NCT01021592 ·Status: COMPLETED
-
Multiple Myeloma and Exercise
NCT01809717 ·Status: COMPLETED ·Phase: NA
-
Plan Development for Giving Teclistamab in the Outpatient Setting
NCT06251076 ·Status: RECRUITING ·Phase: PHASE4
-
Evaluation Study on Performance of Guided Clinical Pharmacy Consultation in Patients With Multiple Myeloma on First Oral Anticancer Treatment
NCT04309942 ·Status: COMPLETED ·Phase: NA
-
Home Treatment With Carfilzomib in Patients With Multiple Myeloma
NCT05620238 ·Status: RECRUITING
-
Cost-Utility Analysis Hospital Versus Home in Multiple Myeloma
NCT03493737 ·Status: COMPLETED
-
Impact of Paramedical Consultations in Oncological Supportive Care in Outpatients With Multiple Myeloma
NCT05355987 ·Status: COMPLETED ·Phase: NA
-
Quality of Life the Danish Multiple Myeloma Patients
NCT02892383 ·Status: COMPLETED
-
Telemonitoring Among Patients With Multiple Myeloma
NCT05964270 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of Comprehensive Geriatric Assessment and Laboratory Biomarkers in Elderly Patients With Multiple Myeloma
NCT05918185 ·Status: COMPLETED
-
Study of Risk Factors and Genetic Association With Bortezomib-induced Peripheral Neuropathy in Multiple Myeloma
NCT03210753 ·Status: UNKNOWN
-
Development of a Standardized Reference Guide for Tuning Adherence to Dispense During a Initial Pharmaceutical Consulting (CP ) to the Patient With Multiple Myeloma Oral Chemotherapy Primocure
NCT04045561 ·Status: COMPLETED
-
Integrative Therapies in Multiple Myeloma
NCT06515249 ·Status: RECRUITING ·Phase: NA
-
Etiology of Multiple Myeloma: A Case-Control Study
NCT00505999 ·Status: UNKNOWN
-
A Multicenter Cross-sectional Study on Mental Health of Patients With Multiple Myeloma
NCT05620420 ·Status: COMPLETED
-
Multiple Myeloma Minimal Residual Disease
NCT02627261 ·Status: COMPLETED
-
A Study of Health-Related Quality of Life in People With Multiple Myeloma Receiving Daratumumab or Lenalidomide
NCT04497961 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2